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Introduction
The more we learn about human genetics and human
variation, the more apparent it becomes that our indivi-
dual make-up has a noticeble impact on the effective-
ness of medications. Urinary bladder cancer is the sixth
leading cause of mortality due to malignant neoplasm
among Polish man in Lodz region. Many genetic and
epigenetic alterations have been identified that contri-
bute directly to the development of bladder tumors. The
aim of the project was the creation of the individual risk
calculator of bladder cancer recurrence using available
clinical data and the results of the long term genetic
research.
Material and methods
Experimental molecular markers (including P53 and
CDKN2a mutations and polymorphisms, assessment the
level of genes expression, loss of heterozygosity), UroVy-
sion test results, HPV infection status and conventional
clinicopathological data were studied in a cohort of 104
patients (92 men) with bladder cancer diagnosed
between November 2006 and June 2008 (the mean age
was 67). 44 lesions were determined to be non-invasive
tumors (pTa), whereas 36 were invasive (pT1-T4).
Tumor grade was noted low (G1) in 46 cases and high
(G2-3) in 34 cases. For modeling the relationship
between the explained variable (time whithout recur-
rence) and explaining variables a multilayer perceptron
was used (a kind of artificial neural network). Its func-
tioning can be compared to how the so called “black
box”. We know what data are introduced, we are
aquinted with the obtained result, however we have no
knowledge of what process takes place inside.
Results
The predicted variable was coded as follows: 0-high risk
of recurrence and death, 1- early recurrence, 2-late
recurrence, 3- very low risk for recurrence. Next, the set
of data was divided into three sub-groups: training (65
cases), validation set (20 cases) and test set (19 cases).
The fact that artificial neural networks create models of
phenomena only on the basis of representative data pre-
viously gathered by investigators is useful in several
aspects. Firstly, for using artificial neural networks a
priori knowledge of the problem in the statistical sense
is not required. Secondly, the construction of the model
may result in identification of new important variables,
which possibly would be ignored using conventional sta-
tistical analysis. Thirdly, it should be noted that the arti-
ficial neural networks are able to deal with lack of data,
the problem which often encountered in clinical
practice.
Conclusion
The calculator proposed by us takes into considerations
clinicopathological, genetic and environmental data (like
tobacco smoking and occupational exposure). To our
knowledge this is first attempt to include a various
genetic variable into the bladder cancer recurrence cal-
culator. We intend to increase the amount of data pre-
sented to the net so the process of net training can be
more effective and it can allow calculating the risk of
disease progression. In our opinion this is the direction
which should be followed, especially in the oncoming
era of personalized healthcare and individual therapy.
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